All news articles
Breast Cancer Now responds to NICE draft guidance rejecting neoadjuvant Perjeta to treat early HER2+ breast cancer
Friday 20 May 2016 General
Our CEO, Baroness Delyth Morgan, comments on draft guidelines issued today by NICE recommending pertuzumab (...
Tuesday 17 May 2016 Scotland
Our Policy and Campaigns Manager in Scotland, Lawrence Cowan, comments on the latest statistics published today....
Monday 16 May 2016 Campaigns and policy
Experts warn that without wider NICE reform, many effective cancer medicines will not be available to patients in...
Breast Cancer Now responds to plans from NHS England to improve cancer services, treatment and care for cancer patients in England
Friday 13 May 2016 Campaigns and policy
Sally Greenbrook, our Policy Manager, comments on how NHS England's new plans may impact on the lives of breast...
Wednesday 11 May 2016 Research
Sally Greenbrook, Policy Manager at Breast Cancer Now, responds to research suggesting high fruit intake during...
Monday 9 May 2016 Research
We respond to research suggesting radiotherapy during surgery could save millions of travel miles for patients...
Sunday 8 May 2016 General
We are delighted to announce the appointment of Catherine Miles as Director of Fundraising.
Friday 29 April 2016 Research
Our response to new research presented today at the ESTRO 35 conference in Turin, which suggests that breast-...
Monday 25 April 2016 Research
Breast Cancer Now-funded research aims to determine why one third of breast cancer patients treated with anti-...